Published in Immunology on June 01, 2005
R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther (2007) 1.63
Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking. PLoS One (2009) 1.23
Gene expression in periodontal tissues following treatment. BMC Med Genomics (2008) 1.05
Structure, function, and localization of Gβ5-RGS complexes. Prog Mol Biol Transl Sci (2009) 0.95
Inherited variants in regulatory T cell genes and outcome of ovarian cancer. PLoS One (2013) 0.93
An atlas of mouse CD4(+) T cell transcriptomes. Biol Direct (2015) 0.93
Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling. Int J Cell Biol (2011) 0.85
R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity. AAPS J (2015) 0.84
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int J Cancer (2013) 0.84
The downstream regulation of chemokine receptor signalling: implications for atherosclerosis. Mediators Inflamm (2013) 0.83
Using gene expression to improve the power of genome-wide association analysis. Hum Hered (2014) 0.82
Association between regulator of G protein signaling 9-2 and body weight. PLoS One (2011) 0.80
RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation. Am J Physiol Lung Cell Mol Physiol (2013) 0.78
Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma. Oncoimmunology (2015) 0.76
Blocking the recruitment of naive CD4(+) T cells reverses immunosuppression in breast cancer. Cell Res (2017) 0.75
RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling. Nat Commun (2015) 0.75
Real time quantitative PCR. Genome Res (1996) 35.79
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42
CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol (2002) 12.73
CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity (2002) 8.28
Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol (2001) 5.95
Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature (1989) 5.80
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med (2001) 5.56
Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med (2003) 4.39
EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell (1996) 4.22
B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med (1998) 3.60
Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity (2003) 3.55
Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol (2002) 3.35
Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity (2003) 3.29
Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature (1996) 2.83
The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol (2000) 2.73
Control of immune pathology by regulatory T cells. Curr Opin Immunol (1998) 2.42
Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae. Mol Cell Biol (1995) 1.99
Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins. Immunity (1998) 1.45
RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J Immunol (2002) 1.33
Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med (1999) 1.31
Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice. Eur J Immunol (2002) 1.25
Independent homeostatic regulation of B cell compartments. Eur J Immunol (1997) 1.19
RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol (2000) 1.19
Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes. J Immunol (1999) 1.14
Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes. J Immunol (2000) 1.11
Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation. J Immunol (2003) 1.08
Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol (2002) 1.03
Specific induction of RGS16 (regulator of G-protein signalling 16) mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor alpha in a calcium-sensitive manner. Biochem J (2000) 0.85
Cyclosporin A therapy differently affects immunological-relevant gene expression following immunization. Immunol Lett (2002) 0.78
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev (2007) 2.56
Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood (2009) 2.23
Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire. J Exp Med (2002) 1.62
A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur J Immunol (2005) 1.51
Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat Immunol (2008) 1.50
Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells. J Immunol (2009) 1.45
Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One (2009) 1.06
New insights into the proliferation and differentiation of early mouse thymocytes. Int Immunol (2004) 1.05
Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol (2009) 1.02
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector. Mol Ther (2006) 1.01
Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. J Proteome Res (2011) 1.01
IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol (2007) 1.00
In vivo and in absence of a thymus, the enforced expression of the Notch ligands delta-1 or delta-4 promotes T cell development with specific unique effects. J Immunol (2005) 0.99
The B lineage potential of thymus settling progenitors is critically dependent on mouse age. Eur J Immunol (2007) 0.97
Peripheral T lymphocytes recirculating back into the thymus can mediate thymocyte positive selection. J Immunol (2008) 0.91
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol (2007) 0.90
Time-resolved quantitative proteome analysis of in vivo intestinal development. Mol Cell Proteomics (2010) 0.90
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.89
Adjuvants and vector systems for allergy vaccines. Immunol Allergy Clin North Am (2011) 0.87
Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development. PLoS One (2008) 0.86
Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress. J Nutr Biochem (2012) 0.84
Influence of gut microbiota on mouse B2 B cell ontogeny and function. Mol Immunol (2011) 0.83
The sequential determination model of hematopoiesis. Trends Immunol (2007) 0.83
Induction of tolerance via the sublingual route: mechanisms and applications. Clin Dev Immunol (2011) 0.83
Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis. Clin Dev Immunol (2011) 0.82
Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine (2010) 0.82
Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy. Int Arch Allergy Immunol (2012) 0.81
In interleukin-7-transgenic mice, increasing B lymphopoiesis increases follicular but not marginal zone B cell numbers. Eur J Immunol (2003) 0.81
Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy. Int Arch Allergy Immunol (2011) 0.81
Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis. Lipids Health Dis (2013) 0.80
The preTCR-dependent DN3 to DP transition requires Notch signaling, is improved by CXCL12 signaling and is inhibited by IL-7 signaling. Eur J Immunol (2011) 0.80
Homeostatic and functional analysis of mature B cells in lambda5-deficient mice. Immunol Lett (2005) 0.80
SLIT prevents the development of eczema in percutaneous allergen-sensitized mice. J Invest Dermatol (2011) 0.80
Problems defining DN2 thymocytes. Immunol Cell Biol (2008) 0.79
A stromal cell free culture system generates mouse pro-T cells that can reconstitute T-cell compartments in vivo. Eur J Immunol (2014) 0.78
Peripheral T cells in the thymus: have they just lost their way or do they do something? Immunol Cell Biol (2009) 0.78
Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma. Vaccine (2013) 0.77
The impact of cell re-entry into the primary lymphoid organs on lymphocyte repertoire and functionality. Immunol Cell Biol (2009) 0.77
Early lymphocyte development in bone marrow and thymus. Swiss Med Wkly (2007) 0.76
Novel routes for allergen immunotherapy: safety, efficacy and mode of action. Immunotherapy (2012) 0.76
Early lymphocyte development in bone marrow and thymus. Swiss Med Wkly (2006) 0.76
Induction of chemokine receptor expression during early stages of T cell development. Immunol Lett (2005) 0.75
What can Venter teach students about ethics? Nature (2002) 0.75
Identification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzae. J Immunol (2011) 0.75
Deoxyguanosine blocks allograft rejection of thymic epithelium but not lymphocyte infiltration and recognition. Eur J Immunol (2002) 0.75
Letters to the Editor. Allergy Asthma Proc (2017) 0.75
Adjuvants and vector systems for the sublingual route. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess (2013) 0.75
Letters to the Editor. Allergy Asthma Proc (2017) 0.75
Molecular and functional characterization of natural allergen extracts. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess (2013) 0.75
Letters to the Editor. Allergy Asthma Proc (2017) 0.75
Enhancing sublingual immunotherapy by systemic or local factors: A role for vitamin D and lingual tonsil? Allergy Asthma Proc (2017) 0.75